UK markets close in 3 hours 7 minutes
  • FTSE 100

    7,494.10
    +5.95 (+0.08%)
     
  • FTSE 250

    19,989.66
    +77.26 (+0.39%)
     
  • AIM

    911.78
    -2.97 (-0.32%)
     
  • GBP/EUR

    1.1818
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2113
    +0.0037 (+0.31%)
     
  • BTC-GBP

    19,120.57
    -179.39 (-0.93%)
     
  • CMC Crypto 200

    539.56
    -17.79 (-3.19%)
     
  • S&P 500

    4,122.47
    -17.59 (-0.42%)
     
  • DOW

    32,774.41
    -58.13 (-0.18%)
     
  • CRUDE OIL

    89.11
    -1.39 (-1.54%)
     
  • GOLD FUTURES

    1,808.60
    -3.70 (-0.20%)
     
  • NIKKEI 225

    27,819.33
    -180.63 (-0.65%)
     
  • HANG SENG

    19,610.84
    -392.60 (-1.96%)
     
  • DAX

    13,584.70
    +49.73 (+0.37%)
     
  • CAC 40

    6,489.85
    -0.15 (-0.00%)
     

Infusion Pumps and Devices: Technologies and Global Markets

·4-min read
ReportLinker
ReportLinker

Report Scope: This report aims to provide a comprehensive picture of the global market for infusion pumps, with both quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding infusion pumps.

New York, July 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Infusion Pumps and Devices: Technologies and Global Markets" - https://www.reportlinker.com/p01658938/?utm_source=GNW


An in-depth analysis of the global infusion pumps market includes historical data and market projections on sales by pump type, therapeutic application, end user, and region.The analysis describes the different types of infusion pumps (general purpose and specialty) and their current and historical market revenues.

The general purpose infusion pumps are categorized into large volume, syringe, electronic ambulatory, and elastomeric. The specialty infusion pumps are divided into insulin infusion pumps, enteral infusion pumps, PCA infusion pumps, and implantable infusion pumps.

This report also examines therapeutic applications for infusion pumps (diabetes management, oncology, pain management/analgesia, nutrition, and other applications) and end users of infusion pumps (hospitals, home care and alternate site care settings).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors and their respective market ranks. The report also discusses technological trends and new product developments.

Report Includes:
- 34 data tables and 69 additional tables.
- An overview of the global market and technologies for infusion pumps and devices
- Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
- Coverage of medical, scientific, technological, social, and economic issues associated with this market and evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
- Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
- Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Intera Oncology, ICU Medical Inc, Cardinal Health and ZYNO Solution LLC

Summary:
It is estimated that more than REDACTED% of hospitalized patients receive infusion therapy.Infusion pumps arewidely used in hospitals, the home and outpatient care environments to deliver fluids such as nutrients,medications, plasma, platelets, lipids, antibiotics, and other therapeutic fluids into a patient’s body incontrolled amounts.

This is done through various clinically accepted routes of administration, which arearterial, epidural, intravenous, intrathecal, subcutaneous, and enteral.

Infusion pumps offer significant advantages over manual administration of infusion therapy, such as administration of accurate and continuous infusion therapy, the ability to deliver fluids at precisely programmed rates or automated intervals, etc.Moreover, the rapid development of pharmaceuticals and prescribed combinations has made infusion therapy more challenging than ever before.

Thus, the use of infusion pumps to reduce infusion errors is growing worldwide. Since the last decade, many highquality infusion pumps with intelligent technologies and services have entered the market to make infusion therapy simpler, smarter and safer.

Though an infusion pump significantly reduces infusion error risks, it does not eliminate them.Infusion errors or failures caused by infusion systems are among the most common health technology hazards, posing severe patient safety risks.

Thus, the demand for “smart” infusion pumps that minimize infusion errors is REDACTED worldwide.Automation and smart technology can drive improved patient safety, ensure timely, effective clinical intervention and help address the shortage of healthcare workers, a reality that is accelerating interest in solutions like these.

With increasing pressure to control healthcare spending per capita, there is an increasing focus on using technology to increase productivity and reduce ancillary costs worldwide.Healthcare payers and providers continue to seek ways to optimize therapies and devices, resulting in improved outcomes, reduced costs, and ultimately, earlier discharge from hospitals, including recovery and treatment in non-acute settings.

Thus, there is increasing demand for safety-driven, patient-focused and clinician-friendly infusion pumps.

Recently, the infusion pump market has been troubled with security concerns and product recalls. The ability to effectively compete in this market segment is determined by the company’s ability to build its brand strength using the development of technological advancements aimed at increasing the quality, reliability, safety, and security of its infusion pumps while at the same time focusing on manufacturing efficiency and cost-effectiveness, which are operationally challenging with evolving product lines.

The global market for infusion pumps was valued at $REDACTED in 2021.The market is projected to reach $REDACTED in 2027, growing at a CAGR of REDACTED% through the forecast period.

The global infusion pump market is expected to grow significantly, driven by macro trends relating to growing and aging populations, increasing chronic and lifestyle-related diseases, and accelerating demand for technologically advanced products. The infusion pump market has also been benefiting from rising healthcare demands in emerging markets.
Read the full report: https://www.reportlinker.com/p01658938/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting